[go: up one dir, main page]

CN116396241A - A preparation method of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid - Google Patents

A preparation method of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid Download PDF

Info

Publication number
CN116396241A
CN116396241A CN202310384645.9A CN202310384645A CN116396241A CN 116396241 A CN116396241 A CN 116396241A CN 202310384645 A CN202310384645 A CN 202310384645A CN 116396241 A CN116396241 A CN 116396241A
Authority
CN
China
Prior art keywords
reaction
ethyl
oxathiazolidine
butyl
dioxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202310384645.9A
Other languages
Chinese (zh)
Inventor
陈建芳
李波
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Youfu Pharmaceutical Technology Co ltd
Original Assignee
Nanjing Youfu Pharmaceutical Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Youfu Pharmaceutical Technology Co ltd filed Critical Nanjing Youfu Pharmaceutical Technology Co ltd
Priority to CN202310384645.9A priority Critical patent/CN116396241A/en
Publication of CN116396241A publication Critical patent/CN116396241A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D291/00Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/02Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms not condensed with other rings
    • C07D291/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明属于医药中间体技术领域,具体涉及一种叔丁基(R)‑4‑乙基‑2,2‑二氧化物‑1,2,3‑氧杂噻唑烷‑3‑羧酸的制备方法,该叔丁基(R)‑4‑乙基‑2,2‑二氧化物‑1,2,3‑氧杂噻唑烷‑3‑羧酸的制备是以(R)‑2‑氨基‑1‑丁醇为起始原料,经过酰化环合反应、Oxone氧化反应、Boc保护反应,共三步反应得到成品。本发明提供的叔丁基(R)‑4‑乙基‑2,2‑二氧化物‑1,2,3‑氧杂噻唑烷‑3‑羧酸的制备方法是一种全新的制备方法,具有安全、环保、易于放大生产的优点。

Figure 202310384645

The invention belongs to the technical field of pharmaceutical intermediates, in particular to the preparation of a tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid Method, the preparation of the tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid is (R)-2-amino- 1-butanol is used as the starting material, and the finished product is obtained through three steps of acylation ring closure reaction, Oxone oxidation reaction, and Boc protection reaction. The preparation method of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid provided by the present invention is a brand-new preparation method, The invention has the advantages of safety, environmental protection and easy scale-up production.

Figure 202310384645

Description

一种叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷- 3-羧酸的制备方法A tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine- The preparation method of 3-carboxylic acid

技术领域technical field

本发明属于医药中间体技术领域,具体涉及一种叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸的制备方法。The invention belongs to the technical field of pharmaceutical intermediates, in particular to the preparation of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid method.

背景技术Background technique

叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸为重要的医药中间体,CAS号为1417287-40-1,分子式为C9H17NO5S。tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid is an important pharmaceutical intermediate, CAS No. 1417287-40-1 , the molecular formula is C 9 H 17 NO 5 S.

经检索,现有叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸的制备方法主要有两种:After retrieval, there are two main methods for preparing tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid:

1)第一种制备方法的原理如下所示:1) The principle of the first preparation method is as follows:

Figure BDA0004173401100000011
Figure BDA0004173401100000011

Ref:1)Journal of Organic Chemistry,2010,vol.75,#3,p.937-940.Ref: 1) Journal of Organic Chemistry, 2010, vol.75, #3, p.937-940.

2)Advanced Synthesis and Catalysis,2015,vol.357,#9,p.2132-2142.2) Advanced Synthesis and Catalysis, 2015, vol.357, #9, p.2132-2142.

上述方法主要采用N-Boc-(R)-2-氨基-1-丁醇为起始物料。步骤一采用氯化亚砜/吡啶进行酰化反应,后处理较为繁琐,环合收率不理想;步骤二采用重金属催化剂三氯化钌,价格昂贵不利于大批量制备;The above method mainly uses N-Boc-(R)-2-amino-1-butanol as the starting material. Step 1 uses thionyl chloride/pyridine for acylation reaction, the post-treatment is more cumbersome, and the cyclization yield is not ideal; Step 2 uses heavy metal catalyst ruthenium trichloride, which is expensive and not conducive to large-scale preparation;

2)第二种制备方法的原理如下所示:2) The principle of the second preparation method is as follows:

Figure BDA0004173401100000012
Figure BDA0004173401100000012

Ref:1)CN202010253576.Ref: 1) CN202010253576.

上述方法主要采用N-Boc-(R)-2-氨基-1-丁醇为起始物料,一步法合成目标产物。但该反应溶剂用量较大,采用毒性较高、安全性更差的磺酰氯作为酰化试剂,难以进行大批量制备。The above method mainly uses N-Boc-(R)-2-amino-1-butanol as the starting material, and synthesizes the target product in one step. However, the amount of solvent used in this reaction is large, and sulfuryl chloride with higher toxicity and worse safety is used as the acylating reagent, which is difficult to prepare in large quantities.

因此,有必要提供一种全新且安全、环保、易于放大生产的叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸的制备方法。Therefore, it is necessary to provide a new and safe, environmentally friendly, easy-to-scale-up production of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3- Methods for the preparation of carboxylic acids.

发明内容Contents of the invention

本发明的目的在于克服传统技术中存在的上述问题,提供一种叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸的制备方法。The purpose of the present invention is to overcome the above-mentioned problems existing in the traditional technology, and to provide a kind of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3- Methods for the preparation of carboxylic acids.

为实现上述技术目的,达到上述技术效果,本发明是通过以下技术方案实现:In order to achieve the above-mentioned technical purpose and achieve the above-mentioned technical effect, the present invention is realized through the following technical solutions:

一种叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸的制备方法,该叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸的制备是以(R)-2-氨基-1-丁醇为起始原料,经过酰化环合反应、Oxone氧化反应、Boc保护反应,共三步反应得到成品。A preparation method of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid, the tert-butyl (R)-4 -Ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid is prepared from (R)-2-amino-1-butanol as starting material, through acyl Cyclization reaction, Oxone oxidation reaction, Boc protection reaction, a total of three steps to obtain the finished product.

进一步地,第一步的反应如式(I)所示,反应后得到中间体A:Further, the reaction of the first step is shown in formula (I), and intermediate A is obtained after the reaction:

Figure BDA0004173401100000021
Figure BDA0004173401100000021
.

进一步地,第一步的反应具体步骤为:将干燥的二氯甲烷、三乙胺、(R)-2-氨基-1-丁醇、4-二甲氨基吡啶依次加入反应釜中搅拌溶解,在氮气保护氛围下以及-20℃温度下搅拌降温,另取二氯甲烷溶解氯化亚砜,向反应体系中滴加,保温反应一段时间;TLC监控原料反应完全,加入饱和碳酸氢钠水溶液淬灭反应,有机相先用饱和氯化铵水溶液、饱和氯化钠水溶液清洗,有机相再用无水硫酸钠干燥,过滤除去干燥剂,滤液减压浓缩,得中间体A。Further, the specific steps of the reaction in the first step are as follows: add dry dichloromethane, triethylamine, (R)-2-amino-1-butanol, and 4-dimethylaminopyridine into the reaction kettle and stir to dissolve, Stir and lower the temperature under a nitrogen protection atmosphere and at a temperature of -20°C, and take another dichloromethane to dissolve thionyl chloride, add dropwise to the reaction system, and keep it warm for a period of time; TLC monitors that the reaction of the raw materials is complete, and then quenched by adding saturated aqueous sodium bicarbonate solution. To quench the reaction, the organic phase was first washed with saturated ammonium chloride aqueous solution and saturated sodium chloride aqueous solution, and then dried with anhydrous sodium sulfate, filtered to remove the desiccant, and the filtrate was concentrated under reduced pressure to obtain intermediate A.

进一步地,第二步的反应如式(II)所示,反应后得到中间体B:Further, the reaction of the second step is shown in formula (II), and intermediate B is obtained after the reaction:

Figure BDA0004173401100000031
Figure BDA0004173401100000031
.

进一步地,第二步的反应具体步骤为:向反应釜中加入乙腈、水,将中间体A加入反应釜中,取过硫酸氢钾复合盐加入反应体系中,升温至80℃搅拌反应一段时间;TLC监控原料反应完全,加入水进行分液,有机相先用饱和氯化钠水溶液洗涤,有机相再用无水硫酸钠干燥,过滤除去干燥剂,滤液减压浓缩除去溶剂得粗品,快速硅胶柱层析,得中间体B。Further, the specific steps of the second step of reaction are: add acetonitrile and water to the reaction kettle, add intermediate A to the reaction kettle, add potassium persulfate compound salt into the reaction system, raise the temperature to 80°C and stir for a period of time ; TLC monitors that the reaction of raw materials is complete, adding water for liquid separation, washing the organic phase with saturated aqueous sodium chloride solution, drying the organic phase with anhydrous sodium sulfate, filtering to remove the desiccant, and concentrating the filtrate under reduced pressure to remove the solvent to obtain a crude product. Column chromatography yields Intermediate B.

进一步地,第三步的反应如式(III)所示,反应后得到成品:Further, the reaction of the third step is shown in formula (III), and the finished product is obtained after the reaction:

Figure BDA0004173401100000032
Figure BDA0004173401100000032
.

进一步地,第三步的反应具体步骤为:将中间体B加入反应釜中,加入乙腈、三乙胺、4-二甲氨基吡啶搅拌均匀,室温下滴加氯甲酸叔丁氧酯,加毕后升温至60℃反应一段时间;TLC监控原料反应完全,冷却至室温,加入饱和碳酸氢钠水溶液淬灭反应,加入乙酸乙酯萃取,水相用乙酸乙酯萃取两次,合并有机相,有机相用无水硫酸镁干燥,过滤除去干燥剂,滤液蒸干,得到叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸成品。Further, the specific steps of the reaction in the third step are as follows: add intermediate B into the reaction kettle, add acetonitrile, triethylamine, and 4-dimethylaminopyridine and stir evenly, add tert-butoxy chloroformate dropwise at room temperature, and complete the addition After that, the temperature was raised to 60°C and reacted for a period of time; TLC monitored the complete reaction of the raw materials, cooled to room temperature, added saturated aqueous sodium bicarbonate solution to quench the reaction, added ethyl acetate for extraction, the aqueous phase was extracted twice with ethyl acetate, and the organic phase was combined. The phase was dried over anhydrous magnesium sulfate, the desiccant was removed by filtration, and the filtrate was evaporated to dryness to obtain tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3 - Carboxylic acid finished products.

进一步地,叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸成品能够通过硅胶柱层析纯化进行精制。Further, the finished product of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid can be purified by silica gel column chromatography.

本发明的有益效果是:The beneficial effects of the present invention are:

本发明中叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸的制备是以(R)-2-氨基-1-丁醇为起始原料,经过酰化环合反应、Oxone氧化反应、Boc保护反应,共三步反应得到成品;这是一种全新的制备方法,具有安全、环保、易于放大生产的优点。In the present invention, the preparation of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid is based on (R)-2-amino- 1-butanol is used as the starting material, and the finished product is obtained through three steps of acylation ring closure reaction, Oxone oxidation reaction, and Boc protection reaction; this is a brand-new preparation method, which has the advantages of safety, environmental protection, and easy scale-up production .

当然,实施本发明的任一产品并不一定需要同时达到以上的所有优点。Of course, implementing any product of the present invention does not necessarily need to achieve all the above advantages at the same time.

附图说明Description of drawings

为了更清楚地说明本发明实施例的技术方案,下面将对实施例描述所需要使用的附图作简单地介绍,显而易见地,下面描述中的附图仅仅是本发明的一些实施例,对于本领域普通技术人员来讲,在不付出创造性劳动的前提下,还可以根据这些附图获得其他的附图。In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the following will briefly introduce the accompanying drawings that are required for the description of the embodiments. Obviously, the accompanying drawings in the following description are only some embodiments of the present invention. Those of ordinary skill in the art can also obtain other drawings based on these drawings without any creative effort.

图1为本发明成品的NMR检测结果示意图一;Fig. 1 is a schematic diagram 1 of the NMR detection result of the finished product of the present invention;

图2为本发明成品的NMR检测结果示意图二;Fig. 2 is the second schematic diagram of the NMR detection result of the finished product of the present invention;

图3为本发明成品的旋光值测定结果示意图;Fig. 3 is the schematic diagram of the measurement result of the optical rotation value of the finished product of the present invention;

图4为本发明成品的LCMS检测结果示意图。Figure 4 is a schematic diagram of the LCMS detection results of the finished product of the present invention.

具体实施方式Detailed ways

下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其它实施例,都属于本发明保护的范围。The following will clearly and completely describe the technical solutions in the embodiments of the present invention with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some, not all, embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without creative efforts fall within the protection scope of the present invention.

本实施例各简称的具体指代如下:The specific references of each abbreviation in this embodiment are as follows:

SM:(R)-2-氨基-1-丁醇SM: (R)-2-amino-1-butanol

DMAP:4-二甲氨基吡啶DMAP: 4-Dimethylaminopyridine

TEA:三乙胺TEA: Triethylamine

DCM:二氯甲烷DCM: dichloromethane

Oxone:过硫酸氢钾复合盐Oxone: Potassium persulfate complex salt

Boc-Cl:氯甲酸叔丁氧酯Boc-Cl: tert-butoxy chloroformate

Boc:叔丁氧羰基Boc: tert-butoxycarbonyl

MeCN:乙腈MeCN: Acetonitrile

本发明的具体实施例为:Specific embodiments of the present invention are:

实施例1Example 1

一种叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸的制备方法,该叔丁基(R)-4-乙基-2,2-二氧化物-1,2,3-氧杂噻唑烷-3-羧酸的制备是以(R)-2-氨基-1-丁醇为起始原料,经过酰化环合反应、Oxone氧化反应、Boc保护反应,共三步反应得到成品。A preparation method of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid, the tert-butyl (R)-4 -Ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid is prepared from (R)-2-amino-1-butanol as starting material, through acyl Cyclization reaction, Oxone oxidation reaction, Boc protection reaction, a total of three steps to obtain the finished product.

第一步的反应如式(I)所示,反应后得到中间体A:The reaction of the first step is shown in formula (I), obtains intermediate A after the reaction:

Figure BDA0004173401100000051
Figure BDA0004173401100000051
.

第一步的反应具体步骤为:将干燥的DCM(3.0L)、TEA(340.1g,1.5eq)、SM(200g,1.0eq)、DMAP(54.8g,0.2eq)依次加入反应釜中搅拌溶解,氮气保护下-20℃搅拌降温,另取DCM(1L)溶解氯化亚砜(280.4g,1.05eq),向反应体系中滴加,1h加毕,保温反应4h。TLC监控原料反应完全,加入饱和碳酸氢钠水溶液(2L)淬灭反应,有机相用饱和氯化铵水溶液(2L)洗一次,饱和氯化钠水溶液(2L)洗一次,有机相无水硫酸钠干燥2h,过滤除去干燥剂,滤液减压浓缩得中间体A粗品油状物273.7g,收率90.2%。The specific steps of the first step of the reaction are: add dry DCM (3.0L), TEA (340.1g, 1.5eq), SM (200g, 1.0eq), DMAP (54.8g, 0.2eq) into the reaction kettle and stir to dissolve , Stir and cool down at -20°C under the protection of nitrogen, and dissolve thionyl chloride (280.4g, 1.05eq) in DCM (1L), add dropwise to the reaction system, add 1h, keep warm for 4h. TLC monitors that the reaction of the raw material is complete, adding saturated aqueous sodium bicarbonate (2L) to quench the reaction, washing the organic phase once with saturated aqueous ammonium chloride (2L), washing once with saturated aqueous sodium chloride (2L), and washing the organic phase with anhydrous sodium sulfate After drying for 2 h, the desiccant was removed by filtration, and the filtrate was concentrated under reduced pressure to obtain 273.7 g of intermediate A crude oil, with a yield of 90.2%.

质谱:MS-ESI:136.0[M+H]+ Mass Spectrum: MS-ESI: 136.0 [M+H] +

第二步的反应如式(II)所示,反应后得到中间体B:The reaction of the second step is shown in formula (II), obtains intermediate B after the reaction:

Figure BDA0004173401100000052
Figure BDA0004173401100000052
.

第二步的反应具体步骤为:向反应釜中加入乙腈(3L)、水(1L),将中间体A(273.7g,1.0eq)加入反应釜中,取Oxone(1367.5g,1.1eq)加入反应体系中,升温至80℃搅拌反应4h。TLC监控原料反应完全,加入水(2L)分液,有机相用饱和氯化钠水溶液(3L)洗涤一次,有机相无水硫酸钠干燥,过滤,滤液减压浓缩除去溶剂得粗品,快速硅胶柱层析,得中间体B纯品288.6g,收率94.3%。The specific steps of the second step of the reaction are: add acetonitrile (3L) and water (1L) to the reaction kettle, add intermediate A (273.7g, 1.0eq) to the reaction kettle, take Oxone (1367.5g, 1.1eq) and add In the reaction system, the temperature was raised to 80° C. and stirred for 4 h. TLC monitors that the reaction of the raw material is complete, adding water (2L) to separate the liquid, the organic phase is washed once with a saturated aqueous sodium chloride solution (3L), the organic phase is dried over anhydrous sodium sulfate, filtered, the filtrate is concentrated under reduced pressure to remove the solvent to obtain a crude product, and the fast silica gel column Chromatography gave 288.6 g of pure intermediate B, with a yield of 94.3%.

质谱:MS-ESI:152.0[M+H]+Mass spectrum: MS-ESI: 152.0 [M+H] + .

第三步的反应如式(III)所示,反应后得到成品:The reaction of the third step is shown in the formula (III), and the finished product is obtained after the reaction:

Figure BDA0004173401100000062
Figure BDA0004173401100000062
.

第三步的反应具体步骤为:将IM2(288.6g,1.0eq.)加入反应釜中,加入MeCN(4L)、TEA(288.0g,1.5eq)、DMAP(46.4g,0.2eq)搅拌均匀,室温下滴加Boc-Cl(389.3g,1.5eq),加毕后升温至60℃反应8h,TLC监控原料反应完全,冷却至室温,加入饱和碳酸氢钠水溶液(4L)淬灭反应,加入乙酸乙酯(4L)萃取,水相用乙酸乙酯(2L)萃取两次,合并有机相,无水硫酸镁干燥,过滤,蒸干,所得粗品经柱层析纯化,得成品产物432.4g,收率:90.5%。The specific steps of the third step reaction are: add IM2 (288.6g, 1.0eq.) into the reactor, add MeCN (4L), TEA (288.0g, 1.5eq), DMAP (46.4g, 0.2eq) and stir evenly, Boc-Cl (389.3g, 1.5eq) was added dropwise at room temperature, and after the addition was completed, the temperature was raised to 60°C for 8 hours. TLC monitored the complete reaction of the raw materials, cooled to room temperature, and quenched the reaction by adding saturated aqueous sodium bicarbonate solution (4L), and adding acetic acid Ethyl ester (4L) was extracted, and the aqueous phase was extracted twice with ethyl acetate (2L). The organic phases were combined, dried over anhydrous magnesium sulfate, filtered, and evaporated to dryness. The obtained crude product was purified by column chromatography to obtain 432.4 g of the finished product. Rate: 90.5%.

质谱:MS-ESI:274.1[M+Na]+Mass spectrum: MS-ESI: 274.1 [M+Na] + .

成品相关测试及结果如图1至图4所示。The related tests and results of the finished product are shown in Figures 1 to 4.

以上公开的本发明优选实施例只是用于帮助阐述本发明。优选实施例并没有详尽叙述所有的细节,也不限制该发明仅为具体实施方式。显然,根据本说明书的内容,可作很多的修改和变化。本说明书选取并具体描述这些实施例,是为了更好地解释本发明的原理和实际应用,从而使所属技术领域技术人员能很好地理解和利用本发明。本发明仅受权利要求书及其全部范围和等效物的限制。The preferred embodiments of the invention disclosed above are only to help illustrate the invention. The preferred embodiments do not exhaust all details nor limit the invention to specific implementations. Obviously, many modifications and variations can be made based on the contents of this specification. This description selects and specifically describes these embodiments in order to better explain the principle and practical application of the present invention, so that those skilled in the art can well understand and utilize the present invention. The invention is to be limited only by the claims, along with their full scope and equivalents.

Claims (8)

1. A process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid, characterised in that: the preparation of the tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid takes (R) -2-amino-1-butanol as an initial raw material, and the product is obtained through three steps of reaction, namely acylation cyclization reaction, oxone oxidation reaction and Boc protection reaction.
2. The process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 1, characterised in that the reaction in the first step is as shown in formula (I) to give intermediate a:
Figure FDA0004173401090000011
3. the process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 2, characterised in that the reaction of the first step comprises the following specific steps: sequentially adding dried dichloromethane, triethylamine, (R) -2-amino-1-butanol and 4-dimethylaminopyridine into a reaction kettle, stirring and dissolving, stirring and cooling at-20 ℃ under the nitrogen protection atmosphere, taking dichloromethane to dissolve sulfoxide chloride, dropwise adding into a reaction system, and reacting for a period of time at a constant temperature; TLC monitors that the raw materials are reacted completely, saturated sodium bicarbonate aqueous solution is added for quenching reaction, an organic phase is firstly washed by saturated ammonium chloride aqueous solution and saturated sodium chloride aqueous solution, the organic phase is dried by anhydrous sodium sulfate, a drying agent is removed by filtration, and filtrate is concentrated under reduced pressure to obtain an intermediate A.
4. A process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 3, characterised in that the reaction in the second step is as shown in formula (II) to give intermediate B after reaction:
Figure FDA0004173401090000012
5. the process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 4, wherein the reaction in the second step comprises the specific steps of: acetonitrile and water are added into a reaction kettle, an intermediate A is added into the reaction kettle, potassium hydrogen persulfate composite salt is added into a reaction system, and the temperature is raised to 80 ℃ and the mixture is stirred for reaction for a period of time; TLC monitors that the raw materials are completely reacted, water is added for separating, an organic phase is washed by saturated sodium chloride aqueous solution, the organic phase is dried by anhydrous sodium sulfate, a drying agent is removed by filtration, the filtrate is decompressed and concentrated to remove the solvent to obtain a crude product, and the crude product is subjected to rapid silica gel column chromatography to obtain an intermediate B.
6. The process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 5, wherein the reaction in the third step is of formula (III) to give the final product after reaction:
Figure FDA0004173401090000021
7. the process for the preparation of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 6, wherein the reaction in the third step comprises the following specific steps: adding the intermediate B into a reaction kettle, adding acetonitrile, triethylamine and 4-dimethylaminopyridine, uniformly stirring, dropwise adding tert-Ding Yangzhi chloroformate at room temperature, and heating to 60 ℃ for reaction for a period of time after adding; TLC monitors the completion of the reaction of the raw materials, cools to room temperature, quench the reaction with saturated aqueous sodium bicarbonate, extract with ethyl acetate, extract the aqueous phase twice with ethyl acetate, combine the organic phases, dry the organic phases with anhydrous magnesium sulfate, filter to remove the desiccant, evaporate the filtrate to dryness, get the finished product of tert-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid.
8. The process for producing t-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid according to claim 7, wherein the finished product of t-butyl (R) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid is purified by silica gel column chromatography.
CN202310384645.9A 2023-04-12 2023-04-12 A preparation method of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid Pending CN116396241A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202310384645.9A CN116396241A (en) 2023-04-12 2023-04-12 A preparation method of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202310384645.9A CN116396241A (en) 2023-04-12 2023-04-12 A preparation method of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid

Publications (1)

Publication Number Publication Date
CN116396241A true CN116396241A (en) 2023-07-07

Family

ID=87007097

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202310384645.9A Pending CN116396241A (en) 2023-04-12 2023-04-12 A preparation method of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid

Country Status (1)

Country Link
CN (1) CN116396241A (en)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008148202A1 (en) * 2007-06-08 2008-12-11 Kanata Chemical Technologies Inc. Method for the preparation of aminophosphine ligands and their use in metal catalysts
WO2011071725A1 (en) * 2009-12-07 2011-06-16 Boehringer Ingelheim International Gmbh Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core
CN103012386A (en) * 2012-12-26 2013-04-03 浙江普洛得邦化学有限公司 Preparation method of five-membered cyclic sulphate
CN108290843A (en) * 2015-10-01 2018-07-17 百时美施贵宝公司 Biaryl based kinase inhibitors
CN111303078A (en) * 2020-04-02 2020-06-19 苏州爱玛特生物科技有限公司 Synthesis method of tert-butyl 1,2, 3-thiazolidine-3-carboxylate 2, 2-dioxide compound
CN115141175A (en) * 2022-07-04 2022-10-04 多氟多新材料股份有限公司 Method for preparing cyclic sulfate

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008148202A1 (en) * 2007-06-08 2008-12-11 Kanata Chemical Technologies Inc. Method for the preparation of aminophosphine ligands and their use in metal catalysts
WO2011071725A1 (en) * 2009-12-07 2011-06-16 Boehringer Ingelheim International Gmbh Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core
CN103012386A (en) * 2012-12-26 2013-04-03 浙江普洛得邦化学有限公司 Preparation method of five-membered cyclic sulphate
CN108290843A (en) * 2015-10-01 2018-07-17 百时美施贵宝公司 Biaryl based kinase inhibitors
CN111303078A (en) * 2020-04-02 2020-06-19 苏州爱玛特生物科技有限公司 Synthesis method of tert-butyl 1,2, 3-thiazolidine-3-carboxylate 2, 2-dioxide compound
CN115141175A (en) * 2022-07-04 2022-10-04 多氟多新材料股份有限公司 Method for preparing cyclic sulfate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RONGWEI GUO等: ""Synthesis of Chiral Aminophosphines from Chiral Aminoalcohols via Cyclic Sulfamidates"", J. ORG. CHEM., vol. 75, 31 December 2010 (2010-12-31), pages 937 - 940 *

Similar Documents

Publication Publication Date Title
CN112574163B (en) Method for synthesizing Brazilin natural product (+) -Brazilin
CN116396241A (en) A preparation method of tert-butyl (R)-4-ethyl-2,2-dioxide-1,2,3-oxathiazolidine-3-carboxylic acid
CN103508999A (en) Maxacalcitol synthesizing intermediate and preparation method and application thereof
CN116396240A (en) Preparation method of tert-butyl (S) -4-ethyl-2, 2-dioxide-1, 2, 3-oxathiazolidine-3-carboxylic acid
CN106366057A (en) Synthetic method of sofosbuvir intermediate
CN115010638B (en) Synthesis method of Nemactetvir intermediate
CN111018678A (en) Preparation method of high-purity 3-phenoxy bromopropane
CN116514864B (en) Preparation method of (2S, 4R) -1- (tert-butyloxycarbonyl) -4- (tert-butyldimethylsilyloxy) -2-methylpyrrolidine-2-carboxylic acid
CN113387903A (en) Synthesis method of parecoxib sodium impurity
CN108191737B (en) Preparation method of N-(2-methylthiophenyl)isoindole-1,3-dione compound
CN108299269B (en) A kind of synthetic method of MC-1568
CN107417728B (en) A kind of abietyl phosphine derivatization reagent maleopimaric acid monoethyl phosphoryl chloride for nuclear magnetic resonance chirality detection and preparation method thereof
CN112142629B (en) Preparation method of 3-aminosulfonylalanine
CN116478076A (en) Preparation method of (2S, 4S) -1-tert-butoxycarbonyl-2- (difluoromethyl) -4-hydroxypyrrolidine
CN115894503B (en) A method for preparing an azacyclopentane derivative
CN114716340B (en) Preparation method of iopromide intermediate
CN116496314B (en) A preparation method of (2S, 4S)-1-(tert-butyloxycarbonyl)-4-(tert-butyldimethylsilyloxy)-2-methylpyrrolidine-2-carboxylic acid
CN116640119B (en) Preparation method of pomalidomide derivative
CN110845445A (en) Connecting body, preparation method and application thereof, and thalidomide-based PROTACs intermediate and application thereof
CN115784967A (en) Synthesis method of nitroisoindolinone compounds
CN116496195A (en) Preparation method of (R) -4, 4-difluoro pyrrolidine-2-carboxylic acid
CN118184571A (en) Synthesis method of trelagliptin succinate impurity compound
CN110041285B (en) A kind of preparation method of 2,4,5-tri-substituted oxazole compounds
RU2785963C1 (en) Method for producing a condensed tricyclic compound and a corresponding intermediate
CN107629039A (en) The preparation method and intermediate of deuterated acrylamide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20230707